Mechanical thrombectomy in patients with heart failure: the Italian registry of Endovascular Treatment in Acute Stroke.
Acute ischemic stroke
Heart failure
Left ventricular ejection fraction
Mechanical thrombectomy
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
14
12
2022
accepted:
26
04
2023
medline:
12
9
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Heart failure (HF) is the second most important cardiac risk factor for stroke after atrial fibrillation (AF). Few data are available on mechanical thrombectomy (MT) in acute ischemic stroke (AIS) patients with HF. The source of data is the multicentre Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS). All AIS patients ≥ 18 years receiving MT were categorised in two groups: HF and no-HF. Baseline clinical and neuroradiological findings on admission were analysed. Of 8924 patients, 642 (7.2%) had HF. Compared to the no-HF group, HF patients had higher prevalence of cardiovascular risk factors. Rate of complete recanalisation (TICI 2b-3) was 76.9% in HF vs 78.1% in no-HF group (p = 0.481). Rate of symptomatic intracerebral haemorrhage at 24-h non-contrast computed tomography (NCCT) was 7.6% in HF vs 8.3% in no-HF patients (p = 0.520). At 3 months, 36.4% of HF patients and 48.2% of no-HF patients (p < 0.001) had mRS 0-2, and mortality was, respectively, 30.7% and 18.5% (p < 0.001). In multivariate logistic regression, HF was independently associated with mortality at 3 months (OR 1.53, 1.24-1.88 95% CI, p < 0.001). In multivariate ordinal regression, HF patients had a probability of transitioning to a higher mRS level of 1.23 (1.05-1.44 95% CI, p = 0.012). The propensity score analysis of two groups matched for age, sex, and NIHSS at admission yielded the same results. MT is safe and effective in HF patients with AIS. Patients with HF and AIS suffered from higher 3-month mortality and unfavourable outcome regardless of acute treatments.
Sections du résumé
BACKGROUND
BACKGROUND
Heart failure (HF) is the second most important cardiac risk factor for stroke after atrial fibrillation (AF). Few data are available on mechanical thrombectomy (MT) in acute ischemic stroke (AIS) patients with HF.
METHODS
METHODS
The source of data is the multicentre Italian Registry of Endovascular Treatment in Acute Stroke (IRETAS). All AIS patients ≥ 18 years receiving MT were categorised in two groups: HF and no-HF. Baseline clinical and neuroradiological findings on admission were analysed.
RESULTS
RESULTS
Of 8924 patients, 642 (7.2%) had HF. Compared to the no-HF group, HF patients had higher prevalence of cardiovascular risk factors. Rate of complete recanalisation (TICI 2b-3) was 76.9% in HF vs 78.1% in no-HF group (p = 0.481). Rate of symptomatic intracerebral haemorrhage at 24-h non-contrast computed tomography (NCCT) was 7.6% in HF vs 8.3% in no-HF patients (p = 0.520). At 3 months, 36.4% of HF patients and 48.2% of no-HF patients (p < 0.001) had mRS 0-2, and mortality was, respectively, 30.7% and 18.5% (p < 0.001). In multivariate logistic regression, HF was independently associated with mortality at 3 months (OR 1.53, 1.24-1.88 95% CI, p < 0.001). In multivariate ordinal regression, HF patients had a probability of transitioning to a higher mRS level of 1.23 (1.05-1.44 95% CI, p = 0.012). The propensity score analysis of two groups matched for age, sex, and NIHSS at admission yielded the same results.
CONCLUSION
CONCLUSIONS
MT is safe and effective in HF patients with AIS. Patients with HF and AIS suffered from higher 3-month mortality and unfavourable outcome regardless of acute treatments.
Identifiants
pubmed: 37199875
doi: 10.1007/s10072-023-06830-9
pii: 10.1007/s10072-023-06830-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3577-3585Informations de copyright
© 2023. Fondazione Società Italiana di Neurologia.
Références
Schumacher K, Kornej J, Shantsila E, Lip GYH (2018) Heart failure and stroke. Curr Heart Fail Rep 15(5):287–296. https://doi.org/10.1007/s11897-018-0405-9
doi: 10.1007/s11897-018-0405-9
pubmed: 30062623
pmcid: 6132785
Agarwal M, Apostolakis S, Lane DA, Lip GY (2014) The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review. Clin Ther 36(9):1135–1144. https://doi.org/10.1016/j.clinthera.2014.07.015
doi: 10.1016/j.clinthera.2014.07.015
pubmed: 25146364
Pullicino P, Homma S (2010) Stroke in heart failure: atrial fibrillation revisited? J Stroke Cerebrovasc Dis 19(1):1–2. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.09.002
doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002
pubmed: 20123219
Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, Wang TJ, Levy D, Benjamin EJ, Ho JE (2016) Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation 133(5):484–492. https://doi.org/10.1161/CIRCULATIONAHA.115.018614
doi: 10.1161/CIRCULATIONAHA.115.018614
pubmed: 26746177
pmcid: 4738087
Scherbakov N, Doehner W (2018) Heart-brain interactions in heart failure. Card Fail Rev 4:87–91. https://doi.org/10.15420/cfr.2018.14.2
doi: 10.15420/cfr.2018.14.2
pubmed: 30206482
pmcid: 6125712
Kim MS, Kim JJ (2015) Heart and brain interconnection - clinical implications of changes in brain function during heart failure. Circ J 79:942–947. https://doi.org/10.1253/circj.CJ-15-0360
doi: 10.1253/circj.CJ-15-0360
pubmed: 25891994
Smit-Fun V, Buhre WF (2016) The patient with chronic heart failure undergoing surgery. Curr Opin Anaesthesiol 29:391–396. https://doi.org/10.1097/ACO.0000000000000335
doi: 10.1097/ACO.0000000000000335
pubmed: 26978592
Okada A, Sugano Y, Nagai T, Takashio S, Honda S, Asaumi Y, NaDEF Investigators et al (2016) Prognostic value of prothrombin time international normalized ratio in acute decompensated heart failure - a combined marker of hepatic insufficiency and hemostatic abnormality. Circ J 80:913–923. https://doi.org/10.1253/circj.CJ-15-132
doi: 10.1253/circj.CJ-15-132
pubmed: 26924077
Eikelboom JW, Connolly SJ (2012) Warfarin in heart failure. N Engl J Med 366:1936–1938. https://doi.org/10.1056/NEJMe1202504
doi: 10.1056/NEJMe1202504
pubmed: 22551103
Abdul-Rahim AH, Fulton RL, Frank B, McMurray JJ, Lees KR, VISTA collaborators (2015) Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA. Eur J Neurol 22(1):163–9. https://doi.org/10.1111/ene.12548
doi: 10.1111/ene.12548
pubmed: 25370204
Siedler G, Sommer K, Macha K, Marsch A, Breuer L, Stoll S, Engelhorn T, Dörfler A, Arnold M, Schwab S, Kallmünzer B (2019) Heart Failure in Ischemic Stroke: Relevance for Acute Care and Outcome. Stroke 50(11):3051–3056. https://doi.org/10.1161/STROKEAHA.119.026139
doi: 10.1161/STROKEAHA.119.026139
pubmed: 31558143
Palumbo V, Baldasseroni S, Nencini P, Pracucci G, Arba F, Piccardi B et al (2012) The coexistence of heart failure predicts short term mortality, but not disability, in patients with acute ischemic stroke treated with thrombolysis: the florence area registry. Eur J Intern Med 23:552–557. https://doi.org/10.1016/j.ejim.2012.03.015
doi: 10.1016/j.ejim.2012.03.015
pubmed: 22863434
Sobolewski P, Kozera G, Szczuchniak W, Sobota A, Chwojnicki K, Gruchała M, Nyka WM (2018) Cerebral thrombolysis in patients with ischemic stroke and heart failure. Neurol Neurochir Pol 52(5):593–598. https://doi.org/10.1016/j.pjnns.2018.08.003
doi: 10.1016/j.pjnns.2018.08.003
pubmed: 30170703
Schnieder M, von Glasenapp A, Hesse A, Psychogios MN, Bähr M, Hasenfuß G, Schroeter MR, Liman J (2019) Heart failure is not associated with a poor outcome after mechanical thrombectomy in large vessel occlusion of cerebral arteries. Stroke Res Treat 1(2019):4695414. https://doi.org/10.1155/2019/4695414
doi: 10.1155/2019/4695414
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, DAWN Trial Investigators et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 378:11–21. https://doi.org/10.1056/NEJMoa1706442
doi: 10.1056/NEJMoa1706442
pubmed: 29129157
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 372:1019–1030. https://doi.org/10.1056/NEJMoa1414905
doi: 10.1056/NEJMoa1414905
pubmed: 25671798
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 372:1009–1018. https://doi.org/10.1056/NEJMoa1414792
doi: 10.1056/NEJMoa1414792
pubmed: 25671797
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, REVASCAT Trial Investigators et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 372:2296–2306. https://doi.org/10.1056/NEJMoa1503780
doi: 10.1056/NEJMoa1503780
pubmed: 25882510
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, SWIFT PRIME Investigators et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 372:2285–2295. https://doi.org/10.1056/NEJMoa1415061
doi: 10.1056/NEJMoa1415061
pubmed: 25882376
Mocco J, Zaidat OO, von Kummer R, Yoo AJ, Gupta R, Lopes D, THERAPY Trial Investigators* et al (2016) Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke. 47:2331–2338. https://doi.org/10.1161/STROKEAHA.116.013372
doi: 10.1161/STROKEAHA.116.013372
pubmed: 27486173
Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, THRACE Investigators. Mechanical et al (2016) thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 15:1138–1147. https://doi.org/10.1016/S1474-4422(16)30177-6
doi: 10.1016/S1474-4422(16)30177-6
pubmed: 27567239
Mangiafico S, Pracucci G, Saia V, Nencini P, Inzitari D, Nappini S, Vallone S, Zini A, Fuschi M, Cerone D et al (2015) The Italian registry of endovascular treatment in acute stroke: rationale, design and baseline features of patients. Neurol Sci 36(6):985–993. https://doi.org/10.1007/s10072-014-2053-5.Erratum.In:NeurolSci.2015Oct;36(10):1975-8
doi: 10.1007/s10072-014-2053-5.Erratum.In:NeurolSci.2015Oct;36(10):1975-8
pubmed: 25567080
ISO-SPREAD – Stroke prevention and educational awareness diffusion, Ictus cerebrale: Linee guida italiane di prevenzione e trattamento, Vol VIII, Luglio 2016.
https://isa-aii.com/linee-guida/linee-guida-attuali/
Mangiafico S, Consoli A, Renieri L, Rosi A, De Renzis A, Vignoli C, Capaccioli L (2013) Semi-quantitative and qualitative evaluation of pial leptomeningeal collateral circulation in acute ischemic stroke of the anterior circulation: the Careggi Collateral Score. Ital J Anat Embryol 118(3):277–287
pubmed: 24640591
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368 . Erratum in: Eur Heart J. 2021 Oct 14.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X
doi: 10.1016/S0140-6736(07)61602-X
Takahashi S, Ishizuka K, Hoshino T, Mizuno T, Nishimura A, Toi S, Kitagawa K (2022) Long-term outcome in patients with acute ischemic stroke and heart failure. Circ J. https://doi.org/10.1253/circj.CJ-21-0937
doi: 10.1253/circj.CJ-21-0937
pubmed: 36503954
Pandey A, Kitzman D, Reeves G (2019) Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management. JACC Heart Fail 7(12):1001–1011. https://doi.org/10.1016/j.jchf.2019.10.005
doi: 10.1016/j.jchf.2019.10.005
pubmed: 31779921
pmcid: 7098068
Pongmoragot J, Lee DS, Park TH, Fang J, Austin PC, Saposnik G; Investigators of the Registry of the Canadian Stroke Network; University of Toronto Stroke Program for the Stroke Outcomes Research Canada (SORCan— www.sorcan.ca ) Working Group. Stroke and heart failure: clinical features, access to care, and outcomes. J Stroke Cerebrovasc Dis. 2016;25(5):1048–1056. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.013 .
Byun JI, Jung KH, Kim YD, Kim JM, Roh JK (2014) Cardiac function and outcome in patients with cardio-embolic stroke. PLoS One 9(4):e95277. https://doi.org/10.1371/journal.pone.0095277
doi: 10.1371/journal.pone.0095277
pubmed: 24760037
pmcid: 3997393
Ois A, Gomis M, Cuadrado-Godia E, Jimenez-Conde J, Rodriguez-Campello A et al (2008) Heart failure in acute ischemic stroke. J Neurol 255(3):385–389. https://doi.org/10.1007/s00415-008-0677-1
doi: 10.1007/s00415-008-0677-1
pubmed: 18343968
Milionis H, Faouzi M, Cordier M, D’Ambrogio-Remillard S, Eskandari A, Michel P (2013) Characteristics and early and long-term outcome in patients with acute ischemic stroke and low ejection fraction. Int J Cardiol 168(2):1082–1087. https://doi.org/10.1016/j.ijcard.2012.11.036
doi: 10.1016/j.ijcard.2012.11.036
pubmed: 23176765
Vemmos K, Ntaios G, Savvari P, Vemmou AM, Koroboki E, Manios E, Kounali A, Lip GY (2012) Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. Eur J Heart Fail 14(2):211–218. https://doi.org/10.1093/eurjhf/hfr172
doi: 10.1093/eurjhf/hfr172
pubmed: 22200911
Cappellari M, Pracucci G, Forlivesi S, Saia V, Nappini S, Nencini P, Inzitari D, Greco L, Sallustio F, Vallone S et al (2020) General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke. Stroke 51(7):2036–2044. https://doi.org/10.1161/STROKEAHA.120.028963
doi: 10.1161/STROKEAHA.120.028963
pubmed: 32517584
Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, Zaidat OO, IMS III Investigators et al (2014) Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 45(3):759–64. https://doi.org/10.1161/STROKEAHA.113.004072
doi: 10.1161/STROKEAHA.113.004072
pubmed: 24473178
pmcid: 3977615